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ABSTRACT
Genomic technologies, such as array comparative
genomic hybridization (aCGH), increasingly offer
definitive gene dosage profiles in clinical samples.
Historically, copy number profiling was limited
to large fresh-frozen tumors where intact DNA
could be readily extracted. Genomic analyses of
pre-neoplastic tumors and diagnostic biopsies are
often limited to DNA processed by formalin-fixation
and paraffin-embedding (FFPE). We present special-
ized protocols for DNA extraction and processing
from FFPE tissues utilizing DNase processing to
generate randomly fragmented DNA. The protocols
are applied to FFPE clinical samples of varied
tumor types, from multiple institutions and of
varied block age. Direct comparative analyses with
regression coefficient were calculated on split-
sample (portion fresh/portion FFPE) of colorectal
tumor samples. We show equal detection of a
homozygous loss of SMAD4 at the exon-level in
the SW480 cell line and gene-specific alterations in
the split tumor samples. aCGH application to a
set of archival FFPE samples of skin squamous
cell carcinomas detected a novel hemizygous
deletion in INPP5A on 10q26.3. Finally we present
data on derivative of log ratio, a particular sensi-
tive detector of measurement variance, for 216
sequential hybridizations to assess protocol reliabil-
ity over a wide range of FFPE samples.
INTRODUCTION
In the eﬀort to expand the utility of current clinical and
surgical practice by including population-based surveil-
lance programs for early cancer detection, vast tissue
resources have been generated that represent potentially
valuable materials for cancer research. Increasingly, the
diagnostic biopsy represents a tissue resource of high
value in the discovery of early oncogenic molecular
events, provided that sensitive molecular surveys can be
performed on limited amounts of tissue ﬁxed in 10%
neutral buﬀered formalin (NBF) and embedded via
standard tissue processing. Given small sample sizes and
the prerequisite requirement for morphologic diagnosis,
clinical tissue samples available for research are often
limited to formalin-ﬁxed, paraﬃn-embedded (FFPE)
samples in tissue blocks. Historically, the diverse and per-
vasive chemical consequences of formalin ﬁxation (1–3)
have been noted in molecular assays, including targeted
PCR-based studies and in situ analyses of cellular proteins
by immunohistochemistry (IHC). Signiﬁcant advances in
IHC applications where FFPE tissues are processed in
automated immunostainers, allow improved antigen
retrieval by manipulation of heat and pH exposure to
eﬀect partial reversal of DNA and protein crosslinking
(3). Experimental gains similar to those in epitope retrieval
in FFPE tissue are now being obtained in the retrieval and
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PCR-based assays (3).
Historically, the experimental measurement and charac-
terization of nucleic acids from FFPE samples have been
inconsistent, with high losses of clinical samples due to
the high variability of the FFPE process. The function
of formalin ﬁxation is tissue preservation by extensive
crosslinking of tissue and cellular proteins. Modiﬁcations
of nucleic acids in this procedure include intra- and inter-
strand cross-linking (2), extensive strand cleavage and
base modiﬁcation (4). The application of genomic
research to such archival samples, however, is limited by
signiﬁcant inter-sample variability in DNA fragment size
and degree of cross-linking. These variables are related to
complex and poorly understood ways on collection and
processing conditions and age of storage of the paraﬃn
block (5,6). When combined with the relative low yields of
extracted nucleic acids, particularly in biopsy samples, the
pre-analytic variability inherent in such samples largely
precludes genome wide analyses of FFPE samples by
high-density microarray experiments (7).
While the diﬃculties of getting representative, readily
labeled DNA from FFPE samples is a serious limit to
the applicability of the method, it is not the only hurdle.
The performance of array comparative genomic hybrid-
ization (aCGH) proﬁling on clinical tumors samples has
clariﬁed the need to determine and quantify tumor
cellularity and the implementation of subsequent cellular
enrichment strategies (8). In a heterogeneous tumor tissue
sample, signal arising from the copy change in the tumor
genome is diluted by the signal arising from the normal,
diploid genome. Scrape macrodissection, a time-eﬀective
sampling method, enriches tumor content, but results
in varying compositions of normal and tumor cell DNA
content due to the admixture of stromal and epithelial
cell populations. Laser capture microdissection is
commonly used to achieve higher cell-type purity
samples in clinical tumors, but at signiﬁcant cost in time
and equipment and limitations in the amount of DNA
obtained. For FFPE-based techniques to be widely appli-
cable, they need to be suﬃciently sensitive to accurately
detect copy changes despite some amount of diluting
normal tissue. Critical to assessment of suitability of
FFPE samples is traditional split sample comparison of
assay performance of standard method (fresh-frozen
sample) versus tested method (FFPE sample). Such
sample pairs, retrospectively collected to account for
age-dependent FFPE eﬀects, have provided high degree
of cross-sample assay sensitivity using BAC arrays (9).
The standard application of comprehensive genome-
scanning studies is to solid tumor samples that were col-
lected as fresh-frozen biopsies. Genome-wide analyses of
small intra-epithelial neoplasias (IEN) are often limited by
both formalin ﬁxation and the small size of most diagnos-
tic biopsies. For example, colorectal adenomas are widely
available in the paraﬃn blocks and have been studied in
small numbers by CGH methods that rely on hybridiza-
tion either to metaphase chromosomes (10,11) or to
DNA probes produced from fairly large chromosomal
segments in BAC arrays (12,13). Genomic studies with
large sample numbers, predominantly on invasive CRCs,
have identiﬁed common, large regions of chromosome loss
and gain involving up to 20% of the genome (14,15).
Strategies to achieve BAC CGH resolution of 1Mb with
small FFPE samples include ﬁndings of uneven success
with either whole genome ampliﬁcation of DNA of
variable sample integrity or with the employment of ﬁne
microdissection (16). Though considerably better than the
5–10Mb resolution oﬀered by metaphase CGH, resolu-
tion in the detection of dosage alterations, including
breakpoints at the gene level is limited by the fairly large
segment size distribution of BAC inserts. More recently,
aCGH, utilizing tens to hundreds of thousands of long
60-mer oligonucleotide probes, provides intragenic resolu-
tion at ranges of 6.5–35kb with suﬃcient sensitivity to
detect intragenic single copy changes (17). Early reports
of application of FFPE samples to the aCGH platform
include the comparison of BAC and aCGH analysis of
prostate tumors (18) and failure by multiple parameters
on skin biopsy split samples that assessed eﬀects of various
ﬁxatives (19). Sample preparation methods in utilizing
FFPE materials are more uneven and diﬃcult to apply
to genome-wide assays. Inferences based on the micro-
array platform and probe design oﬀers insights to
ﬁxation artifact, for example, BAC array suitability to
FFPE samples reﬂects the larger BAC probe sensors
(13,20). To address the minimal starting amount of
tissue material, for example, from small biopsy FFPE
samples, strategies for isothermal ampliﬁcation for whole
genome ampliﬁcation utilizing multiple strand displace-
ment have reported success in FFPE samples (20,21).
Here we report on experiments to determine the appli-
cability of aCGH to FFPE-derived samples using SW480,
HCT116 and HT29 colorectal cancer (CRC) cell lines and
archival clinical samples of CRC and skin squamous cell
carcinoma (SCC). We outline speciﬁc protocols for DNA
extraction and processing from FFPE and demonstrate
that suﬃcient resolution to detect small copy changes in
small genomic regions is retained, despite the altered DNA
template post formalin ﬁxation. Additionally, we present
quality control data from a much larger set of FFPE
samples to support application of the highly sensitive and
speciﬁc assay of aCGH to a broad biological range of
samples ranging from previously studied genomes of cell
lines to a series of archival colorectal samples ranging from
adenomatous precursors through invasive CRC.
MATERIALS AND METHODS
Sample selection
Paraﬃn tissue blocks collected from 1997 to 2004 were
obtained from four separate institutions under Institu-
tional Review Board approval. The majority of paraﬃn
blocks were colorectal samples that included colorectal
adenomas, invasive cancer and normal margin (n=156).
Additional tumor types included non-small cell lung
cancer (n=46) and endometrial/cervical cancer (n=14).
A total of 216 paraﬃn clinical samples were analyzed by
aCGH and grouped by archival age to include 28 samples
of 0–3 years, 30 samples of 4–6 years, 119 samples of 7–10
years and 39 samples of >10 years. The tissues were ﬁxed
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performed on six samples split into fresh-frozen and FFPE
portions at the time of collection. In addition a series of 41
clinical FFPE skin samples of SCC, SCC precursors were
provided by the University of Arizona Cancer Center.
To determine reliability of the DNase protocol we
selected four DNA extracts for comparative testing of
our protocol versus restriction enzyme of AluI/RsaI and
versus no fragmentation method. Genomic reference
DNA was prepared in similar manner to match the respec-
tive fragmentation method and samples labeled and
hybridized in the usual manner. To assess collection site
and age-related artifact the fragmentation test samples
were selected from diﬀerent institutions and were >6
years archival age.
Cell lines
HCT116, HT29 and SW480 cell lines were obtained from
the American Type Culture Collection. Cell lines with
varied X chromosome dosage (GM04626, GM11226 and
GM06061) were obtained from the Coriell Institute. Cell
lines were grown to 70–80% conﬂuence in recommended
media and conditions. Fresh cell harvests were collected
with mild trypsin digestion and DNA extracted with
DNeasy prep kit (Qiagen, Inc.). Cellular pellets for
embedding were created by mixing concentrated cells in
agarose (UltraPure Agarose, Invitrogen) after harvest and
then ﬁxing in 10% buﬀered formalin with mild agitation.
After ﬁxation in NBF for an additional 4–16h, the cell
pellets in agarose were paraﬃn embedded in early 2007.
DNA extraction
Paraﬃn blocks were cut as 12mm sections on standard
charged glass slides and, depending on tissue sample
size, 3–10 slides were deparaﬃnized in xylene. Targeted
regions for sampling were marked on adjacent H&E
section by the study pathologist and recovered by scrape
macro-dissection. The enriched cellular sample was
treated for 72h in Proteinase K at 58 C in buﬀer ATL
(Qiagen). DNA extraction was performed with phe-
nol:chloroform using Phase Lock Gel centrifugation
tubes (Eppendorf), followed by chromatography using a
DNeasy Tissue Kit (Qiagen). Extracted DNA was
quantiﬁed by spectroscopy and sized on a 2% agarose
gel using a 1kb ladder, then stained with Sybr Gold
(Invitrogen).
DNase processing
A detailed protocol is outlined in Supplementary Protocol
1. Brieﬂy, random fragmentation of 5mg of extracted
DNA and 2mg of genomic reference DNA (Promega) is
achieved by time-controlled digestion with a recombinant,
thermolabile shrimp DNase (USB Corp.). The standard
reaction total volume is 10ml. This contains either 2.5mg
of FFPE sample DNA or 1mg of commercial reference
DNA, along with 1ml of a 1:400 dilution of the DNase
enzyme. To obtain 5mg of digested FFPE sample DNA,
two aliquots of 2.5mg are digested separately. The increase
in starting material for the FFPE-extracted DNA, due to
the less eﬃcient template properties for the labeling step,
compensates for sub-optimal DNA template and yields
incorporation rates and DNA synthesis quantities
similar to non-ﬁxed DNA. As mixtures of buﬀers and
enzymes may have varying activity levels or lot-to-lot
variance, the DNase activity is recalibrated whenever
new enzyme, new dilution buﬀer or new reaction buﬀer
is prepared. In a calibration run, genomic reference DNA
is digested in timed increments (3, 5, 7, 9min, etc.) to
achieve desired fragment length (200–400bp). Enzyme
dilutions are freshly prepared on the day of use and can
be held on ice for use within 4–6h. The duration of diges-
tion for FFPE samples is based on the initial distribution
of DNA fragment lengths and an empirically determined
level based on the enzyme’s activity on FFPE samples.
Periodic testing of the DNase batch’s activity on both
the reference and FFPE-extracted DNA is suggested to
insure constancy of fragmentation. Once these fragmenta-
tion proﬁles are determined, adjustments are based on
the initial degree of fragmentation in an FFPE-derived
sample are proportionate. For example, if a sample
with a most fragments longer than 1500bp would be
suﬃciently digested in 5min, then samples with most
fragments >800bp would be suﬃciently digested in
2min. After optimal digestion time is determined,
DNase is added to sample DNA in reaction buﬀer
solution and incubated at 25 C for the appropriate time
in a thermocycler. The DNase enzyme is inactivated at
70 C for 30min. Digested DNA product is sized on a
2% agarose gel using a 100bp ladder (Invitrogen) and
stained with a 1X working solution of SYBR Gold gel
(Invitrogen) post-stain.
Array CGH
Digested DNA products, FFPE sample (5mg) and sex mis-
matched commercial genomic reference DNA (Promega)
(2mg) were labeled with Cy 5 and Cy 3 ﬂuorescent dUTP,
respectively, using the Bioprime Array CGH Genomic
Labeling System (Invitrogen). Post-labeling spectroscopy
analysis was used to determine total DNA yield, and 8mg
of lableled DNA of both sample and reference were
hybridized to the aCGH array. Hybridizations were per-
formed on either Agilent 44K or 244K feature microarrays
for aCGH using 60-mer oligonucleotide probes (Agilent
Technologies, Palo Alto). The initial 43 FFPE samples
were hybridized to 44K arrays and the remaining 173
samples were hybridized to 244K arrays as the denser
arrays became commercially available. We performed 13
split hybridizations of same FFPE sample, same DNA
extract split hybridizations on both 44K and 244K
density microarrays. Hybridizations to the arrays were
at 65 C, rotating the array chamber at 10 rpm for 40h.
Hybridized arrays were then washed per the manufac-
turer’s instructions. Microarray slides were scanned on
an Agilent DNA Microarray Scanner, with images
analyzed by Feature Extraction and CGH Analytics
software (Agilent Technologies).
Data analysis
Extracted, normalized data from the slide images
were analyzed with CGH Analytics software (Agilent
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ADM-1 (22), with a threshold of 6.0 (standard deviations
of the DLRS), and a threshold ﬁlter that requires at least
three contiguous probes with an average absolute value of
the log2 ratio change of 0.30 across the aberration for it
to be called a gain or loss. Pre-analytical variance was
monitored by frequent sample DNA quantiﬁcation to
ensure appropriate amounts and sizes of FFPE product.
Reference genomic DNA (Promega) was a single pool
derived from peripheral blood lymphocytes from 10
male or female individuals. Intra and inter-assay
variance was monitored through utilities provided in the
CGH Analytics software package. QC measures of
average hybridization intensities, of signal to noise ratio
and of the reproducibility documented by identical
replicate probes printed randomly across the array are
taken (22). The absolute value of the log2 ratio variance
from each probe to the next contiguous probe, averaged
over the entire genome is reported as the derivative of the
log ratio spread (DLRS), which provides a particularly
sensitive measure of assay quality. The study of copy
change in chromosomes allows the use of a very
valuable characteristic, the tendency of the genome to
have long segments present at a constant copy value.
Even genomes that have large numbers of segments that
have undergone copy change have the overwhelming
majority of the genome present in runs of speciﬁc copy
levels. There are usually not more than several hundreds
of points along the genome where abrupt copy changes
occur. One can therefore obtain an excellent estimate of
the experimental and technical variance of the assay by
taking the average of the absolute value of the probe-to-
probe diﬀerence in ratio readings. (See Supplement B—
Analysis and Supplement B—Data for details.) The larger
increases in this value which occur between the two probes
at the junctions where an ampliﬁcation or deletion starts
and stops will add only a small inﬂation of the error
estimate since there only a few hundred such inﬂated
values in several hundreds of thousands of true estimates
of the error. A further reﬁnement that removes outliers
due to copy change to produce a more robust representa-
tion of this variance, the spread of the derivative of the log
ratio can be achieved by using the inter-quartile range
(value at the 75th percentile minus value at the 25th per-
centile) as the basis for calculating this spread. (See
Supplement B—Analysis and Supplement B—Data for
details.) Algorithms to exploit this approach (22) have
been developed and included in the Agilent software
package, DNA Analytics, used to process all of the data
reported.
RESULTS
Experimental evidence of oligo-aCGH sensitivity and
resolution
DNA extraction/processing. DNA fragments extracted
from the FFPE samples, as shown in Figure 1a, displayed
a wide size distribution, including some samples with
unexpectedly high fragment lengths. Extensive digestion
with Proteinase K minimized protein conjugates and
allowed maximal recovery of useful DNA template. The
gel sizing of DNA fragments allowed proper adjustment
of DNase digestion time to achieve fragmented DNA
segments of predominantly 200–600bp as shown in
Figure 1b. Two samples, both colorectal advanced
adenomas, failed quality control parameters due to
extensively fragmented DNA and poor labeling. These
were removed from the study. The utility of random
DNA fragmentation for aCGH, achieved by the DNase
method, was tested experimentally by comparing DNase
versus restriction enzyme fragmentation in aCGH
experiments on a series of cell line DNAs that contained
variable numbers of copies of the X chromosome. As
demonstrated in Figure 1c, near identical ratios were
shown in the autosomes while the DNase fragmented
samples showed tighter ratio distributions and average
ratios closer to the expected values for the increasing
number of X chromosomes.
Sensitivity to sample dilution. The sensitivity of aCGH
to detect copy changes in samples where tumor and
normal cells are mixed was examined by proﬁling
varying mixtures of a colorectal tumor cell line, HT29,
with normal female DNA. Figure 2 shows equal detection
of ampliﬁcations and deletions of large regions of chro-
mosome 8 even at a tumor to normal ratio of 30%.
A separate region of 8q showed reliable detection of a
smaller deletion at a ratio of 50% tumor to normal.
Same DNA extract comparison of fragmentation
methods. Same DNA extract from four (4) FFPE
samples was prepared by DNase fragmentation or by
AluI/RsaI fragmentation or by no fragmentation and
hybridized. Feature extraction of hybridization data was
performed and quality control metrics reviewed to include
DLR values as listed in Table 1. The direct labeling of
non-processed DNA samples showed consistently high
DLR and high levels of background nose leading
to few dosage alterations being detected by the ADM-1
algorithm. The AluI/RsaI digested samples showed
signiﬁcantly better DLRs than the non-fragmented
DNA. Still, three of the four hybridizations had DLRs
greater than 0.25, and two of the four samples were
above 0.3 where sensitivity to copy change is signiﬁcantly
impaired. In contrast, all of the DNAse fragmented
samples showed DLRs of 0.25 or less, allowing sensitive
detection of copy changes even in tumors signiﬁcantly
diluted with normal nuclei. The AluI/RsaI results are con-
sistent with the usual high variability seen when molecular
techniques are applied to archival FFPE tissues.
Eﬀects of formalin ﬁxation, cell line samples. The gene
dosages of HCT116 and SW480 cell lines have been
heavily studied with a range of molecular and genomic
methods of varying sensitivities. These colorectal cell
lines thus provide a set of genomes with known copy
number features for comparative analysis of both
platform (Agilent aCGH) performance and of the eﬀects
of FFPE processing on DNA performance. CGH
Analytics software (Agilent, Inc.) was used to determine
dosage alterations from the genomic to sub-gene levels.
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the fresh cell preparation and the FFPE agarose pellets for
each cell line showed remarkable equivalence. Both FFPE
experiments showed minimal to moderate non-speciﬁc
signal ‘noise’; however, aberrations calls by the ADM-1
algorithm were nearly identical for the FFPE and fresh-
frozen samples. Consistent with the MSI phenotype of the
HCT116 cell line few dosage alterations were noted across
the entire genome in both fresh and FFPE DNA samples.
As shown in Figure 3, both HCT116 hybridizations
showed gain over 10q with a sharp shift to loss at 10q26
in the middle of a known tumor suppressor gene, MGMT.
The sharp deﬂection of gain to loss was equally detected in
both DNA samples at the individual probe level. In a
similar fashion, the FFPE and fresh DNA preparations
of SW480 cells showed near identical tracings across the
entire genome. Numerous large-scale gains and losses con-
sistent with the known MSS/genomic instability status of
SW480 were equally detected and called by the algorithm.
A remarkable ﬁnding in the SW480 cell line was the detec-
tion of a four probe homozygous deletion that involved
the 50-end of SMAD4. Both FFPE and fresh preparations
Figure 1. DNase processing: cell line experimental data and FFPE study samples. Gel image (a) shows electrophoresis of FFPE DNA of CRC and
adenoma study samples using 12kb ladder. Gel image (b) shows samples post DNase digestion with optimal fragment length in lanes 1–3 and 7;
incomplete digest lane 4; and over-digest in lanes 5, 6 and 8 (lanes numbered left to right) using 100bp ladder. Box plots (c) show signal intensity
ratios in X chromosome (left) and autosomes (right) for DNase digest versus standard restriction enzyme of Rsa-Alu digest of genomic DNA from
cell lines with increasing divergence in X chromosome dosage. DNase consistently showed ratios closer to theoretical values than Rsa-Alu digest.
Array #1,2 XY/XY; array #3,4 XX/XY; array #5,6 XXX/XY; array 7,8 #XXXX/XY and array 9,10 XXXXX/XY.
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tion spanning base positions 46779898–46814412
within the hemizygous loss of 18q (Figure 3b). This loss
encompasses the ﬁrst exon of SMAD4 (46810581–
46810991). To our knowledge this 35kb homozygous
deletion oﬀers, for the ﬁrst time, a structural correlate
to the well-known SMAD4 null phenotype of the
SW480 cell line.
Eﬀects of formalin ﬁxation, split samples. The stringent
comparison of fresh-frozen and FFPE samples from the
same clinical specimen was performed with details listed in
Table 2. The primary deterrent from making comparative
measurements was inadequate amount of sample of either
fresh frozen (2) or FFPE aliquots (1). These samples
generated from 1.1 to 2.8mg of input DNA after the
Klenow labeling reaction and were determined inadequate
material for microarray hybridization. Of the three
remaining split samples, 244K microarrays were
hybridized to same digest reference genomic DNA. The
concordance ratio of discrete calls of dosage aberrations
for each sample pair was calculated and is presented
in Table 2.
Eﬀects of formalin ﬁxation on aCGH sensitivity, clinical
samples. Extracted DNA from the fresh-frozen and
FFPE portions of six split CRC samples was processed
identically and hybridized on 244K microarrays.
Examination of copy change at the chromosome and
gene levels (Figure 4) shows equal detection of alterations
in the FFPE and fresh-frozen counterparts of sample #103
of a 10p amplicon comprised of four genes including
Abelson Interactor 1 (ABI-1) and a more complex 10q
amplicon with near identical contours. Split sample 549
shows equal detection of a homozygous deletion of
PTEN in a background of chromosome 10 hemizygosity
(Figure 4). This concordance was seen across the genome
Figure 2. Oligo-aCGH assay sensitivity as function of DNA tumor purity. Sensitivity as a function of tumor dilution is shown by DNA dilution
series where colorectal cancer cell line HT29 was progressively diluted with normal DNA with subsequent aCGH analysis. The graphs show
increasing divergence of the log2 ratio measure of 8q focal deletion (green) and broad 8q ampliﬁcation (red) as the percentage of tumor rises.
The 8q ampliﬁcation and 8p deletion are detected at all levels of dilution; the 8q deletion is detected when the tumor is present at levels  50%,
but not at 30%.
Table 1. DLR values of split hybridizations, same DNA extracts,
variable processing
Digestion method Sample ID/institution
191/1 416/2 514/4 456/3
None-direct label 0.486 0.419 0.478 0.405
ALU/RSA1 digest 0.233 0.286 0.331 0.314
DNase I digest 0.211 0.254 0.201 0.214
DNA extractions from CRC FFPE samples from separate institutions
were processed by (a) DNase, (b) AluI/RsaI and (c) no fragmentation.
Superior experimental reliability of DNase hybridizations was shown
across all four samples in contrast to moderate variation in AluI/RsaI-
digested DNA and marked variation in the non-fragmented portion of
FFPE DNA sample.
e9 Nucleic AcidsResearch, 2010,Vol. 38,No. 2 PAGE 6 OF 12Figure 3. aCGH sensitivity in split samples, cell line model. Colorectal cell lines were selected with literature-documented alterations to include
colorectal cancer cell line HCT116 (above) with 10q gain and poorly deﬁned 10 qter alteration. By high resolution aCGH we show clear demarcation
of 10q26 gain to loss in dosage in MGMT, a known cancer gene. In the bottom tracings we show copy proﬁles of chromosome 18 from the SW480
cell line, with expanded tracing to show detection of a four probe homozygous deletion in SMAD4, a gene highly studied and implicated in
progression of CRC. Red- and green-shaded regions show the extent of copy gain and loss. Gray-shaded boxes indicate the location of genes.
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deletions that were equally called in the frozen and
FFPE portions with the exception of one discordant call
of a mono-allelic loss instead of a bi-allelic loss at the
CDKN2 locus. Of the four remaining split samples the
FFPE and fresh-frozen portions showed excellent concor-
dance in sample 104 and 553, with occasional discordant
calls in sample 562. Sample 552 showed very poor labeling
in both the frozen and FFPE portions and was removed
from the study.
Gene-based discovery by aCGH in archival skin SCC
samples. A series of 41 samples representative of normal
skin, SCC precursors and SCC were proﬁled on 44K
aCGH arrays. The objective of this proﬁling was to deter-
mine what genomic aberrations appear ﬁrst and which
aberrations are most common. The most common event
was loss of one chromosome copy at the q-ter region of
chromosome 10, found in SCC in situ as well as
SCC lesions, but not in normal or sun-damaged skin
(Figure 5). Two types of deletion were noted; one type
involving very large regions of loss and the other involving
very regionalized losses near the end of the chromosome.
The ability to see the small regions of deletion make
it possible to reduce the number of candidate genes in
the most frequently altered chromosomal regions that
will be considered as possible candidates to a very small
number. Interestingly, a gene in this region is inositol
polyphosphate-5-phosphatase (INPP5A), which acts on
the signaling molecule, inositol 1,4,5-trisphosphate
(InsP3). InsP3 plays an important role in the PI3K/
AKT/mTOR signaling pathway, which regulates prolifer-
ation and survival. Another phosphatase that acts on
InsP3, is the product of the PTEN gene, which acts as a
tumor suppressor (23). While INPP5A is not heavily
studied, its loss has been reported to be associated with
cell transformation (24).
Performance of aCGH from FFPE samples. The DLR, the
averaged, absolute value of the log2 ratio diﬀerence
between each probe to the next contiguous probe, was
calculated for the 216 FFPE samples with aberration
reporting by the ADM-1 algorithm (Agilent, Inc.). The
lower the DLR, the lower is the probe to probe
variance. DLR ranges are categorized as excellent, good
or poor based on the ability of hybridizations in each
range to reliably detect copy changes in well-characterized
samples. As shown in Table 2, the majority of FFPE
sample hybridizations (61%) had DLRs in the excellent
range and >93% were in the good or excellent range.
DISCUSSION
The adaptation of FFPE samples to molecular research
applications has been hindered by the often large
variations in ﬁxation and processing procedures. Over
the last decade, convergence in these procedures across
many institutions has made it feasible to produce analyt-
ical processes that can be successfully applied to samples
from many clinical sources. This is beginning to allow the
vast potential of clinical FFPE samples with clinical
annotations and long-term outcomes to be realized.
Here, we provide a tailored protocol using DNase treat-
ment to generate random fragmented DNA that can now
be employed in both FFPE and fresh-frozen samples for
downstream aCGH analysis. Our experimental strategies
for examining the performance of the proposed method of
DNA preparation from FFPE samples has relied mainly
on the use of comparisons of equivalent samples of cell
lines or tumors that have been split and stored as either
fresh-frozen or FFPE-processed samples. The standard
quantitative measure that we have employed to assess
the quality achieved in all experiments has been the deriv-
ative of log ratio (DLR). This measure exploits the expec-
tation that the measure of the log2 ratio value between
consecutive probes along a chromosomal segment
should only vary signiﬁcantly if there is an abrupt
change in the copy number in the interval between the
segments. As there are usually less than several hundreds
of segmental copy changes and hundreds of thousands of
consecutive probes, the average of the absolute value of
the diﬀerence in the log2 ratio value between consecutive
probes is a very stringent measure of variance in the rep-
resentation of each of the DNA segments detected by a
probe. This sensitivity is further heightened by using DNA
extracted from lymphocytes, a very high-quality source of
normal diploid DNA as the reference in all experiments.
Any deﬁciencies in the clinical sample of DNA due either
to its processing during the archiving process or to the
processes used to recover it from its archival storage
format are exposed by comparison to a pristine reference.
The reliability of our process in extracting DNA that
yields high-quality aCGH proﬁles in a series of 216
FFPE samples is shown in Table 2. The majority of
samples (79%) perform at a level very close to what can
Table 2. Concordance of copy estimates between paired fresh-frozen and FFPE samples
Paired
samples
Archive
Age (years)
Fresh-frozen
DLR
FFPE
DLR
Number of
probes
All probes (%)
concordance
Number of copy
change calls
Change calls (%)
concordance
HCT116 2 0.18 0.31 236385 99.2 28810 93.5
Pair 1 7 0.27 0.35 236385 95.1 66310 82.5
Pair 2 4 0.26 0.22 236385 96.1 25415 63.4
DNAs from the fresh-frozen and FFPE-paired samples were digested, labeled and hybridized using the same procedure. The only clinical sample
pairs that could be accessed had both fresh-frozen and FFPE DNA that was more degraded than most of the samples that were included in our main
study, and so represent a worst-case estimate. It should be noted that we did not see the large increase in copy change calls made relative to the fresh-
frozen samples that is seen in other studies.
e9 Nucleic AcidsResearch, 2010,Vol. 38,No. 2 PAGE 8 OF 12Figure 4. aCGH sensitivity, equal aberration detection in fresh-frozen/FFPE split samples. Near identical gene dosage measurement in DNA
extractions from split sample, fresh-frozen and FFPE portions by oligo-aCGH by the ADM-1 algorithm (Agilent, Inc) in sample 103 (upper
tracings) and sample 549 (lower tracings). The FFPE tracings (right) show moderate increased signal ‘noise’ compared to tracings from fresh-
frozen portion (left) but contain identical bioinformatics call of amplicon length and contour as shown by high resolution gene view (center, orange).
In sample 549 a PTEN homozygous deletion is equally detected in a background of hemizygous loss of entire chromosome 10. In sample 103, two
distinct amplicons are equally detected with the 10p amplicon containing ABI-1. Red- and green-shaded regions show the extent of copy gain and
loss. Grey-shaded boxes indicate the location of genes.
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A further 14% perform at a level that will provide most
of the copy number information that could be obtained,
for an overall level of 93% of samples being highly infor-
mative. When combined with the observation that copy
number change can be accurately detected even when
diluted by normal tissue levels of 50–70%, it is clear that
reliable research on copy number change on samples from
FFPE archives is quite feasible.
Notwithstanding, challenges in adapting technological
advances in microarray experiments and lessons thereof
are an iterative process as the peer-reviewed techniques
will require robustness and reproducibility. Lack of atten-
tion to FFPE sample preparation remains a critical hin-
drance in the ﬁeld. The application of heat and pH of
buﬀer in the generation of speciﬁc length PCR products
from variably aged FFPE samples is perhaps the most
systematic analyses of the use of FFPE tissue materials.
Prior to our success with the DNase I protocol, our lab-
oratory had explored without moderate success DNA
treatment methods including heat digestion, Kreatech
lableling methods and isothermal ampliﬁcation strategies.
(See Supplement C—Dnase performance versus other
fragmentation methods for details.) The random frag-
mentation approach and DNase I protocol development
outlined utilize an imperfect DNA template obtained
from readily available FFPE clinical samples and
facilitates the application of high throughput genomic
technologies to DNA templates whose functionality as a
template is impaired by attached protein or by DNA
modiﬁcations related to formalin-ﬁxation artifact. We
demonstrate that random fragmentation of FFPE DNA
achieved by a specialized DNase protocol provides repre-
sentative genomic DNA template amendable for quanti-
tative gene dosage measurements that should enable
discovery of functionally relevant targets in colorectal
cancer. We have shown a consistent and eﬃcient DNase
protocol to generate a uniform genomic DNA sample
preparation from FFPE samples that diﬀered widely in
archival age and institutional source. The relative consis-
tency of DNA sample preparation was shown in Table 3
over 216 consecutive hybridizations on same analytic
platform using the DLR metric as a particularly sensitive
measure of experimental variance.
Evidence of the DNase protocol to generate random
fragmentation is provided by several lines of experimental
Figure 5. A frequent genomic aberration in skin SCC. Copy proﬁles of samples representing normal and sun-damaged skin with actinic keratosis
(AK) showed no copy aberrations, while samples of SCC frequently showed single copy loss near the q terminus of chromosome 10. Samples 3, 4 of
SCC in situ (SCCIS) and sample 5 of SCC had very large or whole chromosome loss. Samples 6, 7 and 8 showed very focal copy loss. The minimal
region of common loss in this area is deﬁned by the region between the qter end of the loss in sample 6, and the centromeric end of the loss in sample
7, a region which contains a substantial portion of the INPP5A gene. Shaded boxes indicate regions called as loss. The non-shaded box indicates the
position of the INPP5A gene.
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FFPE aliquot as shown in the congruence of detection of
areas of copy change in paired fresh-frozen and FFPE
samples (Figure 4). When analyzed on aCGH arrays,
these have shown high correlation over the entire
genome, including small areas of change as demonstrated
in the detection of the homozygous loss of the genomic
area containing the ﬁrst exon of SMAD4 (Figure 3) within
a larger region of heterozygous loss as well as a similar
homozygous loss of PTEN in a region of heterozygous
loss (Figure 4). There is usually some price to be paid in
detection incurred with FFPE samples. While not
capturing all of the details revealed by the proﬁle from
the fresh-frozen sample, the FFPE proﬁle captures
the majority of the copy changes and represents a
potent tool for genome-wide surveys. This is further
demonstrated by proﬁling a collection of well-annotated
skin samples (Figure 5). The set of samples included
normal skin, SCC precursors and SCC, allowing
sampling that would show when the earliest aberrations
can be found and what aberrations predominate, a useful
course of study for any cancer where such samples can be
obtained.
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